BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Imstem Biotechnology

Imstem Biotechnology logo

Founded
2012
Geography
United States of America based
Funding
$1.100 M

ImStem Biotechnology is a drug-research platform designed to focus on treatment of heart, vascular and blood system and autoimmune diseases.

Technologies

Stem Cells Startups  

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet